Status:
COMPLETED
Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis
Lead Sponsor:
Mansoura University
Conditions:
the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis
Eligibility:
FEMALE
Phase:
PHASE2
PHASE3
Brief Summary
To date, there is no uniform agreement on the most appropriate therapeutic methods for managing women with uterine adenomyosis and/or adenomyoma who want to preserve their fertility. Management with h...
Detailed Description
This is a prospective, randomized, non-blind trial performed in the period from December 2005 and January 2010 in the teaching hospitals affiliated with Mansoura University (Egypt) and a private pract...
Eligibility Criteria
Inclusion
- Patients included in the study were premenopausal women aged 18-42 years with adenomyosis with abnormal uterine bleeding, unexplained infertility, pelvic pain, dysmenorrhea, or pressure effect
Exclusion
- Excluded subjects included women who had myoma(s) measuring \>2 cm, women with uterine adenomyoma who were under treatment with any type of hormonal therapy more recently than 1 month, and women with a history of major medical problem and/or previous medical or surgical treatment for the problem
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01218581
Start Date
December 1 2005
End Date
January 1 2010
Last Update
October 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt, 35111